Phage display mediated immuno-PCR

被引:74
作者
Guo, Yong-Chao
Zhou, Ya-Feng
Zhang, Xian-En [1 ]
Zhang, Zhi-Ping
Qiao, Yan-Mei
Bi, Li-Jun
Wen, Ji-Kai
Liang, Mi-Fang
Zhang, Ji-Bin
机构
[1] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China
[2] Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China
[3] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
[4] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, Beijing 100052, Peoples R China
关键词
D O I
10.1093/nar/gkl260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immuno-PCR (IPCR) is a powerful detection technology in immunological study and clinical diagnosis due to its ultrasensitivity. Here we introduce a new strategy termed phage display mediated immuno-PCR (PD-IPCR). Instead of utilization of monoclonal antibody (mAb) and chemically bond DNA that required in the conventional IPCR, a recombinant phage particle is applied as a ready reagent for IPCR experiment. The surface displayed single chain variable fragment (scFv) and phage DNA themselves can directly serve as detection antibody and PCR template, respectively. The aim of the design is to overcome shortcoming of low detection sensitivity of scFv so as to largely facilitate the real application of scFv in immunoassay. The idea has been demonstrated by applying hantaan virus nucleocapsid protein (NP) and prion protein (PrP) as detection targets in three experimental protocols (indirect, sandwich and real-time PD-IPCR assays). The detection sensitivity was increased 1000- to 10 000-folds compared with conventional enzyme-linked immunosorbent assays (ELISAs). This proof-of-concept study may serve as a new model to develop an easy to operate, low cost and ultrasensitive immunoassay method for broad applications.
引用
收藏
页数:6
相关论文
共 33 条
[1]   A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins [J].
Adler, M ;
Wacker, R ;
Niemeyer, CM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (02) :240-250
[2]   Hantavirus nucleocapsid protein oligomerization [J].
Alfadhli, A ;
Love, Z ;
Arvidson, B ;
Seeds, J ;
Willey, J ;
Barklis, E .
JOURNAL OF VIROLOGY, 2001, 75 (04) :2019-2023
[3]   Phage display technology: clinical applications and recent innovations [J].
Azzazy, HME ;
Highsmith, WE .
CLINICAL BIOCHEMISTRY, 2002, 35 (06) :425-445
[4]  
BLOCK T, 1989, BIOTECHNIQUES, V7, P756
[5]   In-situ immun-PCR to detect antigens [J].
Cao, Y ;
Kopplow, K ;
Liu, GY .
LANCET, 2000, 356 (9234) :1002-1003
[6]   Improving antibody affinity by mimicking somatic hypermutation in vitro [J].
Chowdhury, PS ;
Pastan, I .
NATURE BIOTECHNOLOGY, 1999, 17 (06) :568-572
[7]   Hantavirus [J].
Clement, JP .
ANTIVIRAL RESEARCH, 2003, 57 (1-2) :121-127
[8]   Stable antibody expression at therapeutic levels using the 2A peptide [J].
Fang, JM ;
Qian, JJ ;
Yi, SL ;
Harding, TC ;
Tu, GH ;
VanRoey, M ;
Jooss, K .
NATURE BIOTECHNOLOGY, 2005, 23 (05) :584-590
[9]   Fluobodies: green fluorescent single-chain Fv fusion proteins [J].
Griep, RA ;
van Twisk, C ;
van der Wolf, JM ;
Schots, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 230 (1-2) :121-130
[10]   Real time quantitative PCR [J].
Heid, CA ;
Stevens, J ;
Livak, KJ ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :986-994